Standard BioTools

Standard BioTools is a company listed under the stock ticker FLDM (US).

They are in:

• Medical Equipment50%
• Biotechnology50%

Acquisition, funding and merger involving Standard BioTools.

• Standard BioTools and SomaLogic have merged  (posted on January 5 2024)..
• SomaLogic and Standard BioTools have announced they will merge  (posted on October 6 2023)..

View the org chart displaying its 44 main executives

Most searched biographies at Standard BioTools

• Michael Egholm, Chief Executive Officer and President
• Tom Carey, Chairman of the Board
• Kathy Hibbs, Director

Popular executive movements at Standard BioTools

• Adam Taich, who was Interim Chief Executive Officer, SomaLogic, is promoted to Chief Strategy Officer  (posted on January 8 2024).
• Shane Bowen, who was Chief Research and Development Officer SomaLogic, is promoted to Chief Technology Officer  (posted on January 8 2024).
• Carlos Paya, Chairman of the Board, has left the company  (posted on January 7 2024).

Click here to view some more movements at Standard BioTools

Create your alert
to follow the executive moves at Standard BioTools.

Standard BioTools has 977 competitors including Philips (Netherlands), Medtronic (Ireland) and Thermo Fisher Scientific (United States (USA)).

Popular M&A news in Medical Equipment

• Medigus will change its company name to Xylo Technologies on Apr 12, 2024. (posted on April 12 2024).
• Johnson & Johnson has announced the acquisition of Shockwave Medical  (posted on April 6 2024).
• Carlsmed has just announced a $52 Million fundraising (posted on March 22 2024).

Popular contacts in Medical Equipment

• Marc Casper - Chairman of the Board, President and Chief Executive Officer at Thermo Fisher Scientific
• Robert Rosenthal - Director at Bruker
• Roy Jakobs - President and Chief Executive Officer at Philips

Learn more about the Medical Equipment industry >

Press releases by Standard BioTools

• Standard BioTools Announces Conference Call and Webcast of Second Quarter 2022 Financial Results | Standard BioTools Inc.
• Press Releases | Standard BioTools Inc.
• Standard BioTools Announces First Quarter 2022 Financial Results | Fluidigm Corporation
• Standard BioTools Announces Conference Call and Webcast of First Quarter 2022 Financial Results | Fluidigm Corporation
• Standard BioTools Launches Hyperion+ Imaging System, the New Standard in High-Plex Spatial Imaging | Fluidigm Corporation
• Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Fluidigm Corporation
• Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc. | Fluidigm Corporation
• Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion | Fluidigm Corporation
• Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global | Fluidigm Corporation
• Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution | Fluidigm Corporation
• View more press releases Close

Social media about Standard BioTools

• Standard BioTools on Wikipedia, Google News & Yahoo Finance
• Standard BioTools on LinkedIn, Twitter & YouTube

Contact by email its executives including Michael Egholm

Call Standard BioTools at +1 650...

View the org chart

Register to receive your alert

Report an error